Potential Breast Cancer Treatment Identified Through Gene Analysis
Author Information
Author(s): Chen Xianghui, Zuo Zanwen, Li Xianbin, Li Qizhang, Zhang Lei, Cichero Elena
Primary Institution: School of Medicine, Shanghai University
Hypothesis
Can a novel prognostic model help identify biomarkers and therapeutic targets for breast cancer?
Conclusion
The study identified ten genes as prognostic signatures for breast cancer and suggested that D231-0058 may be a novel candidate for treatment.
Supporting Evidence
- A total of 230 up- and 325 down-regulated DEGs were identified in breast cancer subtypes.
- The prognostic model was validated with high sensitivity and specificity (AUC value, 0.873).
- D231-0058 showed significant inhibitory activity against breast cancer cells.
Takeaway
Researchers found important genes that can help predict breast cancer outcomes and discovered a new potential drug to fight the disease.
Methodology
The study used data from the GEO database to identify differentially expressed genes and constructed a prognostic model using LASSO and Cox regression analyses.
Participant Demographics
The study included breast cancer patients from various subtypes (HER2, LumA, LumB, TN) and normal individuals.
Statistical Information
P-Value
9.65 × 10−10
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website